Clinical trial 2: “A Biological Study of Resveratrol’s Effects on Notch-1 Signaling in Subjects with Low Grade Gastrointestinal Tumors” is the work of Emily R. Winslow from the University of Wisconsin, Madison. This evidence concerns the gene NOTCH1 and digestive system neoplasm.